Risk factors of postoperative deep vein thrombosis (DVT) under low molecular weight heparin (LMWH) prophylaxis in patients with thoracolumbar fractures caused by high-energy injuries

被引:20
|
作者
Wang, Haiying [1 ]
Pei, Honglei [2 ]
Ding, Wenyuan [1 ]
Yang, Dalong [1 ]
Ma, Lei [1 ]
机构
[1] Hebei Med Univ, Hosp 3, Dept Spinal Surg, 139 Ziqiang St, Shijiazhuang 050051, Hebei, Peoples R China
[2] Hebei Med Univ, Hosp 1, Dept Orthopaed, Shijiazhuang 050000, Hebei, Peoples R China
关键词
Deep vein thrombosis; Low molecular weight heparin; Thoracolumbar fracture; High-energy injury; Risk factor; QUALITY-OF-LIFE; VENOUS THROMBOEMBOLISM; PULMONARY-EMBOLISM; SPINAL SURGERY; SINGLE-CENTER; PREVALENCE; PREVENTION; DIAGNOSIS; DISEASE; TRAUMA;
D O I
10.1007/s11239-020-02192-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine the incidence of DVT and to evaluate the risk factors of DVT under LMWH prophylaxis in patients with thoracolumbar fractures caused by high-energy injuries postoperatively. A total of 534 patients from January 2016 to November 2019 were included in this retrospective study. Medical record data, including demographic data, perioperative variables, and laboratory results, were collected. LMWH prophylaxis was used for DVT in all the patients. The incidence and risk factors of DVT after surgery were identified by logistic regression analysis and receiver operating characteristic (ROC) curve analysis. The overall incidence of postoperative DVT was 18.91% (101/534). Three patients (0.56%) had proximal DVT and ninety-eight (18.35%) patients had distal DVT. The incidence of postoperative DVT in patients with thoracic fractures was 26.80% and 15.50% with lumbar fractures. The multivariate analysis showed that six risk factors increased the incidence of postoperative DVT, including advanced age, decreased lower extremity motor, blood transfusion, duration of bed rests, fibrinogen (FIB), and D-dimer. The ROC analysis indicated that the diagnostic value of D-dimer was highest whose area under the ROC curves (AUC) value was 0.754. Despite LMWH prophylaxis, the risk of postoperative DVT is still very high, especially in thoracic fracture. Advanced age, decreased lower extremity motor, blood transfusion, duration of bed rests, FIB, and D-dimer are risk factors for DVT. Moreover, the diagnostic value of D-dimer is the highest among these factors.
引用
收藏
页码:397 / 404
页数:8
相关论文
共 50 条
  • [41] A comparison of indobufen and low-molecular-weight heparin in the prevention of deep vein thrombosis in patients after total hip arthroplasty: a prospective randomized controlled study
    Huo, Jia
    Li, Mengnan
    Liu, Bo
    Liu, Jia
    Ma, Wenhui
    Wu, Tao
    Li, Huijie
    Han, Yongtai
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (03): : 2720 - 2728
  • [42] Delivery of low molecular weight heparin for prophylaxis against deep vein thrombosis using a novel, needle-less injection device (J-Tip®)
    Hollingsworth, SJ
    Hoque, K
    Linnard, D
    Corry, DG
    Barker, SGE
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2000, 82 (06) : 428 - 431
  • [43] Deep venous thrombosis prophylaxis with low molecular weight heparin and elastic compression in patients having total hip replacement - A randomised controlled trial
    Kalodiki, EP
    Hoppensteadt, DA
    Nicolaides, AN
    Fareed, J
    Gill, K
    Regan, F
    AlKutoubi, A
    Cunningham, DA
    Birch, R
    Harris, N
    Hunt, D
    Johnson, J
    Marx, C
    INTERNATIONAL ANGIOLOGY, 1996, 15 (02) : 162 - 168
  • [44] Low-Molecular-Weight Heparin Prophylaxis of Deep Vein Thrombosis for Older Patients with Restricted Mobility Propensity Analyses of Data from Two Multicentre, Cross-Sectional Studies
    Labarere, Jose
    Sevestre, Marie-Antoinette
    Belmin, Joel
    Legagneux, Annie
    Barrellier, Marie-Therese
    Thiel, Helene
    Le Roux, Philippe
    Pernod, Gilles
    Bosson, Jean-Luc
    DRUGS & AGING, 2009, 26 (03) : 263 - 271
  • [45] Out of hospital treatment with subcutaneous low molecular weight heparin in patients with acute deep-vein thrombosis: a prospective study in daily practice
    Zidane, Majida
    van Hulsteijn, Leonard H.
    Brenninkmeijer, Bernard J.
    Huisman, Menno, V
    HAEMATOLOGICA, 2006, 91 (08) : 1052 - 1058
  • [46] Comparison of unfractionated versus low molecular weight heparin for deep vein thrombosis prophylaxis during breast and pelvic cancer surgery: Efficacy, safety, and follow-up
    Heilmann, L
    Tempelhoff, GFV
    Kirkpatrick, C
    Schneider, DM
    Hommel, G
    Pollow, K
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 1998, 4 (04) : 268 - 273
  • [47] Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study
    Lavau-Denes, Sandrine
    Lacroix, P.
    Maubon, A.
    Preux, P. M.
    Genet, D.
    Venat-Bouvet, L.
    Labourey, J. L.
    Martin, J.
    Slaouti, P.
    Tubiana-Mathieu, N.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (01) : 65 - 73
  • [48] A RANDOMIZED CONTROLLED TRIAL OF A LOW-MOLECULAR-WEIGHT HEPARIN (ENOXAPARIN) TO PREVENT DEEP-VEIN THROMBOSIS IN PATIENTS UNDERGOING VASCULAR-SURGERY
    FARKAS, JC
    CHAPUIS, C
    COMBE, S
    SILSIGUEN, M
    MARZELLE, J
    LAURIAN, C
    CORMIER, JM
    EUROPEAN JOURNAL OF VASCULAR SURGERY, 1993, 7 (05): : 554 - 560
  • [49] The Effect of Intermittent Pneumatic Compression Device Combined with Low-Molecular-Weight Heparin on the Prevention of Deep Vein Thrombosis in Elderly Patients after Femoral Neck Fracture Surgery
    Li, Chen
    Xie, Xi
    Zheng, Hao-tian
    Gao, Xi
    Li, Cheng-yuan
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2024, 85 (10)
  • [50] Safety of deep venous thrombosis prophylaxis with low-molecular-weight heparin in brain surgery. Prospective study on 746 patients
    Chibbaro, Salvatore
    Tacconi, Leonello
    SURGICAL NEUROLOGY, 2008, 70 (02): : 117 - 121